The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors
Open Access
- 27 March 2001
- Vol. 91 (7) , 1297-1303
- https://doi.org/10.1002/1097-0142(20010401)91:7<1297::aid-cncr1132>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Semen Quality and Reproductive Hormones Before Orchiectomy in Men With Testicular CancerJournal of Clinical Oncology, 1999
- SEMEN QUALITY AND REPRODUCTIVE HORMONES BEFORE AND AFTER ORCHIECTOMY IN MEN WITH TESTICULAR CANCERJournal of Urology, 1999
- ADVANCED TESTICULAR CANCER: UPDATE FOR UROLOGISTSJournal of Urology, 1998
- Testicular Germ-Cell CancerNew England Journal of Medicine, 1997
- Evaluation of long-term toxicity after chemotherapy for testicular cancer.Journal of Clinical Oncology, 1996
- Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experienceBritish Journal of Cancer, 1996
- Clinical and Biochemical Long–Term Toxicity after Postoperative Cisplatin–Based Chemotherapy in Patients with Low-Stage Testicular CancerOncology, 1995
- Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancerAnnals of Oncology, 1994
- Gonadal dysfunction in patients treated for metastatic germ-cell tumors.Journal of Clinical Oncology, 1986
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977